Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on ALXN1850 for Adolescents and Adults with Hypophosphatasia Not Previously Treated with Asfotase Alfa

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Italy Poland +2
  • Study on the Effectiveness and Safety of Ravulizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    France Italy Spain
  • Study on Salbutamol for Improving Muscle Strength in Patients with Congenital Myopathy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • Study on Crizanlizumab for Adolescents and Adults with Sickle Cell Disease Experiencing Vaso-Occlusive Crises

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Finland France The Netherlands Spain
  • Study on the Safety and Effectiveness of Quizartinib for Children and Young Adults with Acute Myeloid Leukemia (AML)

    Not recruiting

    1 1 1
    Investigated Drugs:
    Belgium Denmark France Italy The Netherlands Spain +1
  • Study on the Safety and Effectiveness of Fingolimod and Interferon Beta-1a in Children with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France Germany Romania Slovakia Spain
  • Study on the Safety and Effectiveness of Rilzabrutinib for Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia (ITP)

    Not recruiting

    3 1
    Investigated Drugs:
    France Germany Hungary Italy Norway Poland +1
  • A Phase 4 Study of Crizanlizumab Treatment for Patients with Sickle Cell Disease Who Previously Participated in Novartis Clinical Trials

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium France Germany Italy Spain
  • Study on Dexlansoprazole for Treating and Maintaining Healing of Erosive Esophagitis in Children Aged 2 to 11 Years

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on the Safety and Effectiveness of Dexlansoprazole for Treating Nonerosive GERD in Children Aged 2 to 11 Years

    Not recruiting

    2 1 1
    Investigated Drugs:
    Poland